February 10, 2011 -- NS8, an Israeli pharmaceutical firm, announced the China launch of sertraline, an antidepressant of the SSRI class commonly known as Zoloft. NS8 recently received SFDA approval from the SFDA for 50mg and 100mg tablets of the drug. The company said it is filing several additional ANDAs for new drugs, including some technologically challenging products. More details....
